Back to top
more

VERADIGM INC (MDRX)

(Delayed Data from OTC)

$4.81 USD

4.81
2,099

-0.07 (-1.43%)

Updated Aug 27, 2026 03:52 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (100 out of 247)

Industry: Medical Info Systems

Zacks News

Zacks Equity Research

The Zacks Analyst Blog Highlights: 10x Genomics, Allscripts Healthcare and NextGen Healthcare

The Zacks Analyst Blog Highlights: 10x Genomics, Allscripts Healthcare and NextGen Healthcare

Urmimala Biswas headshot

3 Med Info Stocks to Improve Portfolio Health Amid Coronavirus Woes

Postponement of elective surgeries leading to lower product bookings cloud Zacks-Medical Info Systems industry prospects. However, coronavirus-led demand for contactless services should aid the space. TXG, MDRX, NXGN should be the forerunners.

Zacks Equity Research

Here's Why You Should Retain Allscripts (MDRX) Stock for Now

Investor confidence is high on Allscripts (MDRX) stock, thanks to solid prospects.

Sriparna Ghosal headshot

3 Remote Patient Monitoring Stocks in Focus Amid Coronavirus

In the wake of the pandemic, the remote patient monitoring space continues to thrive on a number of positive developments.

Zacks Equity Research

AllScripts (MDRX) Up 18.4% Since Last Earnings Report: Can It Continue?

AllScripts (MDRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Allscripts Enhances Healthcare Innovation With Patent Program

Allscripts (MDRX) continues to advance healthcare innovation by earning five new application patents.

Zacks Equity Research

Allscripts' Collaboration to Advance Healthcare Innovation

Allscripts (MDRX) partners with Israel's Sheba Medical Center to help enhance healthcare innovation with smarter technology, thereby improving patient outcomes.

Zacks Equity Research

Allscripts (MDRX) Q2 Earnings and Revenues Beat Estimates

Allscripts (MDRX) witnessed decline in core Client Services and Software delivery unit revenues during Q2.

Zacks Equity Research

AllScripts Healthcare (MDRX) Tops Q2 Earnings and Revenue Estimates

AllScripts (MDRX) delivered earnings and revenue surprises of 50.00% and 1.60%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

New Strong Sell Stocks for July 29th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.